Isolated ultrafiltration in moderate congestive heart failure
PG Agostoni,
GC Marenzi,
M Pepi,
E Doria,
A Salvioni,
G Perego,
G Lauri,
F Giraldi,
S Grazi,
and
MD Guazzi
Istituto di Cardiologia dell' Universita degli Studi, Milan, Italy.
OBJECTIVES. The aim of this study was to evaluate whether ultrafiltration is beneficial in patients with moderate congestive heart failure. BACKGROUND. Ultrafiltration is beneficial in patients with severe congestive heart failure. METHODS. We studied 36 patients in New York Heart Association functional classes II and III in stable clinical condition. Eighteen patients (group A) were randomly selected and underwent a single session of ultrafiltration (venovenous bypass, mean [+/- SEM] ultrafiltrate 1,880 +/- 174 ml, approximately 600 ml/h) and 18 (group B) served as control subjects. RESULTS. Two patients in group A and three in group B did not complete the 6-month follow-up study. In group A, soon after ultrafiltration there were significant reductions in right atrial pressure (from 8 +/- 1 to 3.4 +/- 0.7 mm Hg, pulmonary wedge pressure (from 18 +/- 2.5 to 10 +/- 1.9 mm Hg) and cardiac index (from 2.8 +/- 0.2 to 2.3 +/- 0.2 liters/min). During the follow-up period, lung function improved, extravascular lung water (X-ray score) decreased and peak oxygen consumption (ml/min per kg) increased significantly from 15.5 +/- 1 (day -1) to 17.6 +/- 0.9 (day 4), to 17.8 +/- 0.9 (day 30), to 18.9 +/- 1 (day 90) and to 19.1 +/- 1 (day 180). Oxygen consumption at anaerobic threshold (ml/min per kg) also increased significantly from 11.6 +/- 0.8 (day -1) to 13 +/- 0.7 (day 4), to 13.7 +/- 0.5 (day 30), to 15.5 +/- 0.8 (day 90) and to 15.2 +/- 0.8 (day 180). These changes were associated with increased ventilation, tidal volume and dead space/tidal volume ratio at peak exercise. The improvement in exercise performance was associated with a decrease in norepinephrine at rest, a downward shift of norepinephrine kinetics at submaximal exercise and an increase in norepinephrine during orthostatic tilt. None of these changes were recorded in group B. CONCLUSIONS. In patients with moderate congestive heart failure, ultrafiltration reduces the severity of the syndrome.
This article has been cited by other articles:

|
 |

|
 |
 
P. Agostoni and G. Cattadori
Patterns of response diagnostic for cardiac disease
Clinical Exercise Testing,
June 10, 2010;
93 - 107.
[Abstract]
[Fulltext]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Bart
Treatment of Congestion in Congestive Heart Failure: Ultrafiltration Is the Only Rational Initial Treatment of Volume Overload in Decompensated Heart Failure
Circ Heart Fail,
September 1, 2009;
2(5):
499 - 504.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Libetta, V. Sepe, M. Zucchi, P. Pisacco, L. Cosmai, F. Meloni, C. Campana, T. Rampino, C. Monti, L. Tavazzi, et al.
Intermittent haemodiafiltration in refractory congestive heart failure: BNP and balance of inflammatory cytokines
Nephrol. Dial. Transplant.,
July 1, 2007;
22(7):
2013 - 2019.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Agostoni, M. Contini, A. Magini, A. Apostolo, G. Cattadori, M. Bussotti, F. Veglia, D. Andreini, and P. Palermo
Carvedilol reduces exercise-induced hyperventilation: A benefit in normoxia and a problem with hypoxia
Eur J Heart Fail,
November 1, 2006;
8(7):
729 - 735.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. W. Stevenson, T. H. Le Jemtel, E. U. Alt, L. W. Stevenson, T. H. Le Jemtel, and E. U. Alt
Hemodynamic Goals Are Relevant
Circulation,
February 21, 2006;
113(7):
1020 - 1033.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Bart, A. Boyle, A. J. Bank, I. Anand, M. T. Olivari, M. Kraemer, S. Mackedanz, P. A. Sobotka, M. Schollmeyer, and S. R. Goldsmith
Ultrafiltration Versus Usual Care for Hospitalized Patients With Heart Failure: The Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) Trial
J. Am. Coll. Cardiol.,
December 6, 2005;
46(11):
2043 - 2046.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. C. Bourge and J. A. Tallaj
Ultrafiltration: A New Approach Toward Mechanical Diuresis in Heart Failure
J. Am. Coll. Cardiol.,
December 6, 2005;
46(11):
2052 - 2053.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Agostoni, M. Bianchi, A. Moraschi, P. Palermo, G. Cattadori, R. La Gioia, M. Bussotti, and K. Wasserman
Work-rate affects cardiopulmonary exercise test results in heart failure
Eur J Heart Fail,
June 1, 2005;
7(4):
498 - 504.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. K. Gehlbach and E. Geppert
The Pulmonary Manifestations of Left Heart Failure
Chest,
February 1, 2004;
125(2):
669 - 682.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Nanas, J. Nanas, O. Papazachou, C. Kassiotis, A. Papamichalopoulos, J. Milic-Emili, and C. Roussos
Resting Lung Function and Hemodynamic Parameters as Predictors of Exercise Capacity in Patients With Chronic Heart Failure
Chest,
May 1, 2003;
123(5):
1386 - 1393.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Marenzi, G. Lauri, E. Assanelli, M. Grazi, J. Campodonico, G. Famoso, and P. Agostoni
Serum to urinary sodium concentration ratio is an estimate of plasma renin activity in congestive heart failure
Eur J Heart Fail,
October 1, 2002;
4(5):
597 - 603.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Johnson, T. Omland, C. Hall, C. Lucas, O. L. Myking, C. Collins, M. Pfeffer, J.-L. Rouleau, and L. W. Stevenson
Neurohormonal activation rapidly decreases after intravenous therapy withdiuretics and vasodilators for class IV heart failure
J. Am. Coll. Cardiol.,
May 15, 2002;
39(10):
1623 - 1629.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Marenzi, G. Lauri, M. Grazi, E. Assanelli, J. Campodonico, and P. Agostoni
Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure
J. Am. Coll. Cardiol.,
October 1, 2001;
38(4):
963 - 968.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Agostoni, M. Guazzi, M. Bussotti, M. Grazi, P. Palermo, and G. Marenzi
Lack of improvement of lung diffusing capacity following fluid withdrawal by ultrafiltration in chronic heart failure
J. Am. Coll. Cardiol.,
November 1, 2000;
36(5):
1600 - 1604.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Rostagno, G. Galanti, M. Comeglio, V. Boddi, G. Olivo, and G. G. N. Serneri
Comparison of different methods of functional evaluation in patients with chronic heart failure
Eur J Heart Fail,
September 1, 2000;
2(3):
273 - 280.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Pepi, P. Agostoni, G. Marenzi, E. Doria, M. Guazzi, G. Lauri, A. Maltagliati, and M. Guazzi
The influence of diastolic and systolic function on exercise performance in heart failure due to dilated cardiomyopathy or ischemic heart disease
Eur J Heart Fail,
June 1, 1999;
1(2):
161 - 167.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Agostoni, G. Marenzi, M. Guazzi, and M. D. Guazzi
Influence of ACE Inhibition on Fluid Metabolism in Chronic Heart Failure and Its Pathophysiologic Relevance
Journal of Cardiovascular Pharmacology and Therapeutics,
October 1, 1996;
1(4):
279 - 286.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Cody, S. H. Kubo, and K. K. Pickworth
Diuretic Treatment for the Sodium Retention of Congestive Heart Failure
Arch Intern Med,
September 12, 1994;
154(17):
1905 - 1914.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Agostoni, R. Pellegrino, C. Conca, J. R. Rodarte, and V. Brusasco
Exercise hyperpnea in chronic heart failure: relationships to lung stiffness and expiratory flow limitation
J Appl Physiol,
April 1, 2002;
92(4):
1409 - 1416.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|